InvestorsHub Logo
Followers 1
Posts 206
Boards Moderated 0
Alias Born 04/06/2013

Re: None

Monday, 11/27/2017 5:57:21 AM

Monday, November 27, 2017 5:57:21 AM

Post# of 43789
Geert needs some sort of partnership to develop LEAPS and Multikine. If the trial was positive, above all for the marketing and even if the trial wasn't entirely 'yes' ,multikine should be still great in combo with new immunologic drug as Keytruda ,Ipilumab and other checkpoints modulators.
I'm surprised that they didn't do any test with these combos, nowadays so popular in cancer immuno-oncology and in bio-stocks. The results should be extremely attractive for funding and partnership.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News